IP Library Assignment 026290/0513
Patent Assignment
Reel/Frame 026290/0513

Change of Name

Recorded: 2011-05-17 Pages: 9
Assignor
MERCK & CO., INC.
Executed: 2009-11-02
Assignee
MERCK SHARP & DOHME CORP.
126 E LINCOLN AVENUE, RY60-30, RAHWAY, NEW JERSEY, 07065
Covered Property (1)
Novel Cyclic Benzimidazole Derivatives Useful as Anti-Diabetic Agents
Patent: 8,563,746 →
Application: 13/125,329 →
Publication: US 2011/0195964
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 17, 2011
From: BAO, JIANMING; LAN, PING; LU, HUAGANG; ROMERO, F. ANTHONY
To: MERCK & CO., INC.
Reel/Frame 026290/0001 →
Assignment of Assignor's Interest May 20, 2011
From: DANG, QUN; CHUNG, DE MICHAEL; GIBSON, TONY S; JIANG, HONGJIAN
To: METABASIS THERAPEUTICS, INC.
Reel/Frame 026316/0154 →
Merger Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
Change of Name Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
Merger Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
Security Interest Oct 18, 2023
From: CYDEX PHARMACEUTICALS, INC.; LIGAND PHARMACEUTICALS INCORPORATED; METABASIS THERAPEUTICS, INC.; PFENEX INC.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065271/0025 →